Linden Thomas Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.47M	Sell	61,250 -1,960	-3%	-$73.3K	0.24%	137
2025 Q4	$2.2M	Sell	63,210 -695	-1%	-$54.6K	0.22%	131
2025 Q3	$5.31M	Buy	63,905 +305	+0.5%	+$22.1K	0.54%	34
2025 Q2	$4.67M	Sell	63,600 -92	-0.1%	-$6.67K	0.51%	37
2025 Q1	$7.27M	Buy	63,692 +468	+0.7%	+$28.5K	0.94%	5
2024 Q4	$3.19M	Buy	63,224 +1,300	+2%	+$68.1K	0.4%	52
2024 Q3	$2.87M	Buy	61,924 +1,051	+2%	+$37.3K	0.39%	57
2024 Q2	$1.98M	Buy	60,873 +2,002	+3%	+$54.8K	0.31%	94
2024 Q1	$1.48M	Buy	58,871 +2,200	+4%	+$52K	0.24%	171
2023 Q4	$1.84M	Buy	56,671 +555	+1%	+$15.2K	0.34%	86
2023 Q3	$1.53M	Buy	56,116 +368	+0.7%	+$10.7K	0.34%	100
2023 Q2	$1.24M	Buy	+55,748	New	+$1.28M	0.28%	142